Inhalable Nanomedicines for Chronic Obstructive Pulmonary Disease: Recent Developments and Translational Barriers.
- DOI
- 10.34172/apb.46836
- Published
- 2026 Jun
- Container
- Advanced pharmaceutical bulletin
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.34172/apb.46836,
title = {Inhalable Nanomedicines for Chronic Obstructive Pulmonary Disease: Recent Developments and Translational Barriers.},
author = {Ainurofiq A and Rosalin EA and Istiyono MS and Maharani NA and Fauzy R and Sugiharti SN and Safa YF},
year = {2026},
journal = {Advanced pharmaceutical bulletin},
doi = {10.34172/apb.46836},
url = {https://doi.org/10.34172/apb.46836}
}RIS
TY - JOUR TI - Inhalable Nanomedicines for Chronic Obstructive Pulmonary Disease: Recent Developments and Translational Barriers. AU - Ainurofiq A AU - Rosalin EA AU - Istiyono MS AU - Maharani NA AU - Fauzy R AU - Sugiharti SN AU - Safa YF PY - 2026 JO - Advanced pharmaceutical bulletin DO - 10.34172/apb.46836 UR - https://doi.org/10.34172/apb.46836 ER -
APA
A, A., EA, R., MS, I., NA, M., R, F., SN, S., & YF, S. (2026). Inhalable Nanomedicines for Chronic Obstructive Pulmonary Disease: Recent Developments and Translational Barriers.. Advanced pharmaceutical bulletin. https://doi.org/10.34172/apb.46836
Source records
- pubmed · retrieved 2026-11-10T19:01:09.733Z